Skip to content
MedsAcross

Brand family

Lotensin HCT

Benazepril and Hydrochlorothiazide · Validus Pharmaceuticals
United States
Presentations
3
Markets
1

Lotensin HCT is a brand of Benazepril and Hydrochlorothiazide marketed by Validus Pharmaceuticals, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Benazepril and Hydrochlorothiazide
Brand owner
Validus Pharmaceuticals
Registered in
United States
Strengths and forms
10 mg/12.5 mg tablet, 20 mg/12.5 mg tablet, 20 mg/25 mg tablet

All presentations

MedicineManufacturerRegisterAvailability
Lotensin HCT 10 mg/12.5 mg tabletOralValidus PharmaceuticalsUS FDAAvailable on request
Lotensin HCT 20 mg/12.5 mg tabletOralValidus PharmaceuticalsUS FDAAvailable on request
Lotensin HCT 20 mg/25 mg tabletOralValidus PharmaceuticalsUS FDAAvailable on request

Brand names and trademarks belong to their owners and are used only to identify products.

Request Lotensin HCT

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.